Operational Intent: These questions will be asked of each funded recipient (62 states and jurisdictions) and funded sub-recipient3 to determine for which performance measures they should respond. Recipients and sub-recipients will only be asked to provide
data for those performance measures that correspond to the outcomes and activities for which they used Hospital Preparedness Program Cooperative Agreement COVID-19 Supplemental Funding.
1.1 Sub-recipient Question on Facility and Organization Type
PM 1: Please select the sub-recipient type that most closely represents your facility or organization:
-
Health care coalition
-
Emergency medical services (EMS)/pre-hospital care (includes 911 and public safety answering points)
-
State/jurisdiction Special Pathogen Treatment Center (SPTC)
-
Other health care facility/organization (drop down list) 4
1.2 Recipient and Sub-Recipient Funding
Program Performance Measure |
Data Point(s) |
Data Entity |
Calculation |
|---|
| PM 2: Total amount of funding and amount provided per sub-award (including 1st and 2nd rounds of funding)5 | Amount Hospital Preparedness Program Cooperative Agreement COVID-19 Supplemental Funding (in whole dollars) provided per sub-award
Total amount of funding provided to each recipient will be prepopulated
| Recipient | N/A |
|---|
| PM 3: Percent of funding used to support recipient direct costs (Recipient-level allowable direct cost cannot exceed 10%) | No additional data collection - reference PM 2 | Recipient | Recipient-level direct cost = (amount of funding in whole dollars retained by the recipient for activities and funding management / total recipient funding) x 100% |
|---|
1.3 Estimated Funding by Target Outcomes
PM 4: Select the target outcomes (one or more) that your facility or organization directly used Hospital Preparedness Program Cooperative Agreement COVID-19 Supplement Funding to achieve. For each targeted outcome for which your facility or organization used supplemental funding, indicate the estimated number of funding dollars used for the associated outcome. Please leave all other sections blank.
Targeted Outcome |
Estimated number of funding dollars used for associated activities |
|---|
Update the recipient’s special pathogens concept of operations (CONOPS) for health care system response to COVID-19 to include approaches for the assessment, transport, and treatment of persons suspected or confirmed to have COVID-19. Updates to the CONOPS may include: - Ensure a physician is in the state or jurisdiction emergency operations center full time6 to manage patient facility assignments
- Update the existing patient transport plan to include an approach for intra- and inter-state transport of potential or confirmed COVID-19 patients
| |
|---|
Improve and maintain health care worker readiness for COVID-19 and other special pathogens: - Provide health care facility-level training of staff, specifically focusing on health care worker safety when caring for COVID-19
- patients or PUIs (e.g., PPE donning/doffing, rapid identification and isolation of a patient, safe treatment protocols, and the integration of behavioral health support) and early recognition, isolation, and activation of the facility’s updated plan
- Purchase PPE in accordance with the Centers for Disease Control (CDC) guidelines and with attention to supply chain shortages, and share, in real time, situational awareness regarding PPE models/types and supply levels with their HCCs and state or jurisdiction public health department
- Conduct just-in-time training and final preparations to ensure state/jurisdiction special pathogen treatment centers can provide surge capacity and are able to accept a COVID-19 patient in cases where other facilities have exceeded capacity
- Receive and participate in training, peer review, and consultations on their readiness to ensure adequate preparedness and trained clinical staff knowledgeable in treating patients with COVID-19 in the U.S.
Ensure the competency of health care workers to identify, assess, and treat suspected or confirmed patients with COVID-19 and maintain continuity of operations for
| |
|---|
Examine and enhance physical infrastructure to ensure infection control7 for COVID-19 preparedness and response, as necessary: - Reconfigure patient flow in emergency departments to provide isolation capacity for PUIs for COVID-19 and other potentially infectious patients
- Examine physical infrastructure needs, which may include minor retrofitting, adapting, or creating inpatient care areas for enhanced infection control (e.g., donning/doffing rooms)
- Consider alternative or innovative models to reconfigure patient flow or transition to inpatient care, as necessary, such as leveraging alternative care sites (e.g., ambulatory surgical centers) or telemedicine to ensure all patients reach care
- Identify alternate care sites (on facility grounds or within close proximity) and additional sites (offsite) for sub-acute care patients to increase capacity
- Ensure capability to maintain continuity of operations, leveraging alternative or innovative models, such as alternate care sites or telemedicine to support other critical operations.
- Support clinical laboratories’ capability and capacity for COVID-19 response
- Ensure capability and capacity to handle COVID-19 contaminated waste
| |
|---|
Collaborate with multiple and diverse provider types to ensure capabilities to care for target populations: - Including a focus on individuals at-risk for high morbidity and mortality from COVID-19 in the development and execution of activities described above, including collaborating with health care facilities that directly serve these individuals such as long term residential and home health care
| |
|---|
| Support clinical care providers in their implementation of crisis care8 by developing and/or implementing crisis standards of care as necessary with support from medical ethicists (and potentially state public health officials) | |
|---|
3 Sub-recipients are: Health care coalitions, Emergency medical services (EMS)/pre-hospital care (includes 911 and public safety answering points), State/jurisdiction Special Pathogen Treatment Centers, and other health care facilities/organizations defined in footnote one.
4 The terms and conditions for this cooperative agreement were intentionally worded broadly to provide flexibility to recipients. “Other health care facilities/organizations” may include, but not are not limited to: support services (pharmacy, blood bank, medical supply chain), home and residential care (includes long-term care, home health agencies, skilled nursing facilities, etc.), acute care hospitals, and hospital systems. Recipients are permitted and encouraged to provide sub-awards to facilities outside their membership.
5 The first tranche of funding was released to recipients on March 30, 2020 with a required distribution timeline of 30 days for subawards to SPTCs. The second tranche of funding was released to recipients on May 25, 2020, with a required distribution timeline of 30 days for subawards to SPTCs. No requirement was instituted for the timeline for execution of sub-awards with other facilities and organizations.
6 In this context, the National Healthcare Preparedness Programs (NHPP) Branch defines a full-time physician as a physician that is dedicated and assigned to support the jurisdictional emergency operations center (EOC) with patient load-balancing coordination. This EOC physician should have insight into available resources at hospitals and other health care facilities.
7 Centers for Disease Control and Prevention. Accessed August 2020. “Transmission-Based Precautions.”
<< Previous ---------
Top of Page ---------
Next >>
